Lindsay J Caverly1, Tanner J Caverly2, Linda M Kalikin3, Bridget K Foster3, Richard H Simon4, John J LiPuma3. 1. Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI 48109, United States. Electronic address: caverlyl@med.umich.edu. 2. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, United States; Center for Clinical Management Research, Veterans Affairs, Ann Arbor, MI 48105, United States. 3. Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI 48109, United States. 4. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, United States.
Abstract
BACKGROUND: Accurate accounting of antibiotic use is necessary for studies comparing the CF airway microbiota across clinically relevant disease states. While poor adherence to chronic therapies is well described for individuals with CF, use patterns of episodic oral antibiotics are less clear. METHODS: Eleven individuals with CF completed daily questionnaires regarding antibiotic use for a mean of 458days. Self-report of episodic oral antibiotic use was compared to antibiotic prescription data in the electronic medical record (EMR). RESULTS: Self-reported use of episodic oral antibiotics differed from EMR data an average of 8.3% of days per subject. The majority of these discrepancies were due to self-reported use of oral antibiotics outside of the EMR-documented dates of antibiotic prescription. CONCLUSIONS: Discrepancies exist between self-reported use of episodic oral antibiotics and EMR data that have implications for studies of the CF airway microbiota.
BACKGROUND: Accurate accounting of antibiotic use is necessary for studies comparing the CF airway microbiota across clinically relevant disease states. While poor adherence to chronic therapies is well described for individuals with CF, use patterns of episodic oral antibiotics are less clear. METHODS: Eleven individuals with CF completed daily questionnaires regarding antibiotic use for a mean of 458days. Self-report of episodic oral antibiotic use was compared to antibiotic prescription data in the electronic medical record (EMR). RESULTS: Self-reported use of episodic oral antibiotics differed from EMR data an average of 8.3% of days per subject. The majority of these discrepancies were due to self-reported use of oral antibiotics outside of the EMR-documented dates of antibiotic prescription. CONCLUSIONS: Discrepancies exist between self-reported use of episodic oral antibiotics and EMR data that have implications for studies of the CF airway microbiota.
Authors: Lisa A Carmody; Jiangchao Zhao; Patrick D Schloss; Joseph F Petrosino; Susan Murray; Vincent B Young; Jun Z Li; John J LiPuma Journal: Ann Am Thorac Soc Date: 2013-06
Authors: Alexandra L Quittner; Jie Zhang; Maryna Marynchenko; Pooja A Chopra; James Signorovitch; Yana Yushkina; Kristin A Riekert Journal: Chest Date: 2014-07 Impact factor: 9.410
Authors: Jiangchao Zhao; Patrick D Schloss; Linda M Kalikin; Lisa A Carmody; Bridget K Foster; Joseph F Petrosino; James D Cavalcoli; Donald R VanDevanter; Susan Murray; Jun Z Li; Vincent B Young; John J LiPuma Journal: Proc Natl Acad Sci U S A Date: 2012-03-26 Impact factor: 11.205
Authors: Michelle N Eakin; Andrew Bilderback; Michael P Boyle; Peter J Mogayzel; Kristin A Riekert Journal: J Cyst Fibros Date: 2011-03-31 Impact factor: 5.482
Authors: Avani C Modi; Crystal S Lim; Nami Yu; David Geller; Mary H Wagner; Alexandra L Quittner Journal: J Cyst Fibros Date: 2006-05-05 Impact factor: 5.482
Authors: Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette Journal: Proc Natl Acad Sci U S A Date: 2008-09-23 Impact factor: 11.205
Authors: Daniel J Smith; Alison C Badrick; Martha Zakrzewski; Lutz Krause; Scott C Bell; Gregory J Anderson; David W Reid Journal: Eur Respir J Date: 2014-07-17 Impact factor: 16.671
Authors: Lisa A Carmody; Jiangchao Zhao; Linda M Kalikin; William LeBar; Richard H Simon; Arvind Venkataraman; Thomas M Schmidt; Zaid Abdo; Patrick D Schloss; John J LiPuma Journal: Microbiome Date: 2015-04-01 Impact factor: 14.650
Authors: Leah Cuthbertson; Geraint B Rogers; Alan W Walker; Anna Oliver; Laura E Green; Thomas W V Daniels; Mary P Carroll; Julian Parkhill; Kenneth D Bruce; Christopher J van der Gast Journal: ISME J Date: 2015-11-10 Impact factor: 10.302
Authors: Tara Gallagher; Stefan Riedel; Joseph Kapcia; Lindsay J Caverly; Lisa Carmody; Linda M Kalikin; Junnan Lu; Joann Phan; Matthew Gargus; Miki Kagawa; Simon W Leemans; Jason A Rothman; Felix Grun; John J LiPuma; Katrine L Whiteson Journal: Antimicrob Agents Chemother Date: 2021-01-20 Impact factor: 5.191
Authors: Lindsay J Caverly; Junnan Lu; Lisa A Carmody; Linda M Kalikin; Kerby Shedden; Kristopher Opron; Michelle Azar; Shannon Cahalan; Bridget Foster; Donald R VanDevanter; Richard H Simon; John J LiPuma Journal: Ann Am Thorac Soc Date: 2019-12